Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-07-11 | New | $11,000,000 | $11,000,000 | Equity Only | 06b | SEC link |
| 2024-12-05 | New | $4,200,000 | $4,200,000 | Debt Only | 06b | SEC link |
| 2024-03-05 | New | $8,000,000 | $8,000,000 | Equity Only | 06b | SEC link |
| 2022-11-04 | New | $3,683,209 | $3,683,209 | Equity Only | 06b | SEC link |
| 2022-08-11 | New | $7,114,287 | $7,114,287 | Equity Only | 06b | SEC link |
| 2022-05-23 | New | $9,400,681 | $9,400,681 | Equity Only | 06b | SEC link |
| 2021-12-10 | New | $15,000,000 | $15,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| John J Iii Borer | Director |
| John J. Borer Iii | Director |
| Erica F Gates | Executive |
| Beth J. Hoffman | Director |
| Heikki Lanckriet | Director |
| Eugene Frederick Leffler | Executive |
| Eugene Frederick Leffler, Iii | Executive |
| Hermann Luebbert | Director, Executive |
| Erica L Monaco | Executive |
| Kevin D. Weber | Director |
| Loretta M Wedge | Director |